The work presents a data-driven framework that employs Raman spectroscopy and uncertainty-aware machine learning models to anticipate drug release patterns in different biological media and demonstrates the value of bio-inspired hyperparameter optimization within an uncertainty-aware computational framework.
Abstract
Polysaccharide-based drug delivery systems have to be closely watched in terms of drug release in the body over time if they want to be able to achieve maximum therapeutic effectiveness and maintain controlled bioavailability. The work presents a data-driven framework that employs Raman spectroscopy and uncertainty-aware machine learning models to anticipate drug release patterns in different biological media. A dataset of 155 experimental samples was dealt with, which also included more than 1,500 Raman spectral features, polysaccharide composition, release time, and environmental medium (Control, Patient, Rat, and Dog). Principal Component Analysis (PCA) was implemented for dimensionality reduction, and modeling was done with the help of Gradient Boosting Regression (GBR) and Lasso Regression (Lasso) supported by newly developed bio-inspired optimization algorithms Attack-Leave Optimizer (ALO), Self-Adaptive Bonobo Optimizer (SABO), and Black-Winged Kite Algorithm (BWKA). Besides k-fold cross-validation, Friedman statistical testing, prediction interval bootstrapping, and Pareto front analysis were used to further assess model robustness and uncertainty. Of the hybrid models, GBBW (GBR-BWKA) was able to attain the highest predictive accuracy with R
2
= 0.931 and RMSE = 0.076 on the test set, thus outperforming baseline models and demonstrating the value of bio-inspired hyperparameter optimization within an uncertainty-aware computational framework. The primary contribution of this work is methodological: the integration of prediction interval estimation, multi-environment modeling, and Pareto-based model selection into a single reproducible pipeline applied to a publicly available polysaccharide Raman release dataset. No new experimental data were generated; the framework is offered as a computational tool to complement existing experimental approaches in controlled-release formulation research.
The correct time-course forecasting of the release of a drug contained in a drug-polymer matrix is difficult because drug dissolution is a complex process involving all formulation parameters, which are interdependent and have nonlinear effects. Although the predictive accuracy of machine learning (ML) models is high,...
Mohammed Y. Ghazwani, Yahia Alghazwani, Umme Hani· Frontiers in Medicine· 0 citations
Drug-release profiles from nanocarrier systems are governed by nonlinear and multiphasic physicochemical interactions that are difficult to predict using conventional kinetic models. This study presents a data-driven predictive framework that integrates deep neural networks (DNNs) with three bio-inspired metaheuristi...
Hadil Faris Alotaibi, S. S. Alqahtani· Frontiers in Medicine· 0 citations
Predicting drug release from polymer-based delivery systems remains challenging because release behavior depends on nonlinear interactions among formulation composition, polymer properties, drug characteristics, processing conditions, and time. This study develops an interpretable artificial intelligence framework for...
Mohammed Y. Ghazwani, Yahia Alghazwani, Umme Hani· Frontiers in Medicine· 0 citations
Enhancing the dissolution behavior of poorly water-soluble pharmaceuticals remains an important challenge in drug formulation and manufacturing, since limited aqueous solubility can substantially restrict therapeutic performance. Supercritical-fluid technologies provide a promising route for addressing this limitation,...
Hao-Lin Wu, Hadil Faris Alotaibi, A. S. Fahem et al.· Frontiers in Chemistry· 0 citations
HGB accurately correlated solubility within the investigated data distribution and retained useful predictive ability for compounds excluded from model training, but external validation and additional molecular descriptors are required before extrapolating the model to chemically distinct pharmaceuticals.
S. Alshahrani· Frontiers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.